版本:
中国

BRIEF-Ionis enters into collaboration with Ribo to advance RNA-targeted therapeutics in China

April 18 Ionis Pharmaceuticals Inc

* Ionis enters into collaboration with ribo to advance rna-targeted therapeutics in china

* Ionis pharmaceuticals inc - granted ribo license for right to commercialize in china two ionis generation 2+ antisense drugs in metabolic disease, cancer

* Ionis will receive an undisclosed up-front payment and equity in ribo

* Ionis pharma - ribo will be responsible for conducting multi-year research & drug discovery program to identify drugs that utilize ionis' ssrnai technology

* Ionis pharmaceuticals inc - ionis retains rights to develop and commercialize ssrnai technology and all drugs under collaboration outside of china

* Ribo will provide ionis a royalty-free license to data and intellectual property created under collaboration Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐